Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kyowa Hakko and Lilly report new potent antitumor compounds

Jan. 4, 2002

New dosage form of Atrix's Leuprogel licensed in by Sanofi-Synthelabo

Jan. 4, 2002

Japanese researchers identify new steroid sulfatase inhibitors

Jan. 2, 2002

Sterol derivatives claimed as antiproliferative and antiangiogenic agents

Jan. 2, 2002

ImClone's BLA filing for Erbitux not accepted by FDA

Jan. 2, 2002

ABX-EGF enters phase II trial for colorectal cancer

Jan. 2, 2002

Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503

Dec. 31, 2001

Novel epothilone derivatives from Schering act as microtubule-stabilizing agents

Dec. 31, 2001

Schering discloses new series of antiangiogenic agents

Dec. 31, 2001

AstraZeneca and Lilly to collaborate on clinical trials with ZD-1839 and gemcitabine combination

Dec. 28, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...